Modeling induced pluripotent stem cells from fibroblasts of Duchenne muscular dystrophy patients

International Journal of Neuroscience

Volumn 124, Issue 1, 2014, Pages 12-21

  Luo, Yumei ^a   Fan, Yong ^a   Chen, Xinjie ^a   Yue, Lei ^a   Yu, Bolan ^a   Li, Qing ^a   Chen, Yaoyong ^a   Sun, Xiaofang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell models; Duchene muscular dystrophy; Duplication; Induced pluripotent stem cells; Neural

Indexed keywords

ALKALINE PHOSPHATASE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXON; FIBROBLAST; GENE DUPLICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MODEL; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; SOMATIC CELL;

ALKALINE PHOSPHATASE; CELL DIFFERENTIATION; CELLS, CULTURED; FETUS; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MODELS, BIOLOGICAL; MUSCULAR DYSTROPHY, DUCHENNE; PROTO-ONCOGENE PROTEINS C-MYB; SOXB1 TRANSCRIPTION FACTORS; TERATOMA; TRANSFECTION;

EID: 84890067639     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2013.789514     Document Type: Article

References (23)

1. Monaco AP, Neve RL, Colletti-Feener C, et al. Isolation of candidate cDNAs for portions of theDuchenne muscular dystrophy gene. Nature 1986;323:646-50
2. Hoffman EP, Brown RH, Jr, Kunkel LM. Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-28
3. Den Dunnen JT, Grootscholten PM, Dauwerse JG, et al. Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet 1992;1:19-28
4. Oudet C, Hanauer A, Clemens P, et al. Two hot spots of recombination in theDMDgene correlate with the deletion prone regions. Hum Mol Genet 1992;1:599-603
5. Lalic T, Vossen RH, Coffa J, et al. Deletion and duplication screening in the DMD gene using MLPA. Eur J Hum Genet 2005;13:1231-1234
6. Skuk D, Goulet M, Roy B, et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006;65:371-86
7. Skuk D, Goulet M, Roy B, et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther: The journal of the American Society of Gene Therapy 2004;9:475-82
8. Takahashi K, Tanabe K, OhnukiM, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72
9. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-86
10. Kazuki Y, Hiratsuka M, Takiguchi M, et al. Complete genetic correction of iPS cells from Duchenne muscular dystrophy. Mol Ther 2009;18:386-93
11. Kumazaki T, Kurata S, Matsuo T, et al. Establishment of human induced pluripotent stem cell lines from normal fibroblast TIG-1. Hum Cell 2011;24:96-103
12. Ou Z, Li S, Li Q, et al. Duchenne muscular dystrophy in a female patient with a karyotype of 46,X,i(X)(q10). Tohoku J Exp Med 2010;222:149-153
13. Sun X, Long X, Yin Y, et al. Similar biological characteristics of human embryonic stem cell lines with normal and abnormal karyotypes. Hum Reprod 2008;23:2185-2193
14. Yang J, Cai J, Zhang Y, et al. Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J Biol Chem 2010;285:40303-11
15. Zhang J, LianQ, Zhu G, et al. A human iPSCmodel of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 2010;8:31-45
16. Mayshar Y, Ben-David U, Lavon N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010;7:521-31
17. Cai J, Li W, Su H, et al. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 2010;285: 11227-34
18. Na J, Plews J, Li J, et al. Molecular mechanisms of pluripotency and reprogramming. Stem Cell Res Ther 2010;1:33
19. Watanabe S, Hirai H, Asakura Y, et al. MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells. Stem Cells 2011; 29: 505-16
20. Goudenege S, Lebel C, Huot NB, et al. Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol Ther 2012;20:2153-67
21. Dimos J, Rodolfa K, Niakan K, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-21
22. Luo Y, Fan Y, Zhou B, et al. Generation of induced pluripotent stem cells from skin fibroblasts of a patient with olivopontocerebellar atrophy. Tohoku J Exp Med 2012;226:151-9
23. Li W,Wang X, FanW, et al. Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Hum Mol Genet 2011;21:32-45